↓ Direkt till sidans innehåll
↓ Direkt till sidans sekundära innehåll (sidomenyn)

Träfflista för sökning "WFRF:(Steg Philippe Gabriel) srt2:(2010-2014)"

Sökning: WFRF:(Steg Philippe Gabriel) > (2010-2014)

Resultat 21-24 av 24

Sortera/gruppera träfflistan

Sortering: Träffar per sida:

Numrering	Referens	Omslagsbild	Hitta
21.	Wallentin, Lars, et al. (författare) Response to Letter Regarding Article, "Efficacy and Safety of Apixaban Compared With Warfarin at Different Levels of Predicted International Normalized Ratio Control for Stroke Prevention in Atrial Fibrillation" 2014 Ingår i: Circulation. - 0009-7322 .- 1524-4539. ; 129:2, s. E21-E22 Tidskriftsartikel (refereegranskat)
22.	Wallentin, Lars, et al. (författare) Review of the accumulated PLATO documentation supports reliable and consistent superiority of ticagrelor over clopidogrel in patients with acute coronary syndrome Commentary on : DiNicolantonio JJ, Tomek A, Inactivations, deletions, non-adjudications, and downgrades of clinical endpoints on ticagrelor: Serious concerns over the reliability of the PLATO trial, International Journal of Cardiology, 2013 2014 Ingår i: International Journal of Cardiology. - : Elsevier BV. - 0167-5273 .- 1874-1754. ; 170:3, s. E59-E62 Tidskriftsartikel (refereegranskat)
23.	Wallentin, Lars, et al. (författare) Utilisation of novel anti-platelet agents : evidence, guidelines and proven patients' value 2014 Ingår i: Thrombosis and Haemostasis. - 0340-6245 .- 2567-689X. ; 112:1, s. 12-14 Tidskriftsartikel (övrigt vetenskapligt/konstnärligt)
24.	Åkerblom, Axel, 1977-, et al. (författare) Cystatin C and Estimated Glomerular Filtration Rate as Predictors for Adverse Outcome in Patients with ST-Elevation and Non-ST-Elevation Acute Coronary Syndromes : Results from the Platelet Inhibition and Patient Outcomes Study 2012 Ingår i: Clinical Chemistry. - : Oxford University Press (OUP). - 0009-9147 .- 1530-8561. ; 58:1, s. 190-199 Tidskriftsartikel (refereegranskat)abstract BACKGROUND:We evaluated the predictive ability of cystatin C and creatinine-based estimations of glomerular filtration rate (eGFR), including the Chronic Kidney Disease-Epidemiology (CKD-EPI) equation, in acute coronary syndrome (ACS) patients with (STE-ACS) or without (NSTE-ACS) ST elevation in a large contemporary ACS population.METHODS:Concentrations of cystatin C and creatinine, as well as eGFR at randomization, were measured in 16 401 patients in the Platelet Inhibition and Patient Outcomes (PLATO) study and evaluated as predictors of the composite end point of cardiovascular death or myocardial infarction within 1 year. Two Cox proportional hazards models were used, the first adjusting for clinical characteristics and the second for clinical characteristics plus the biomarkers N-terminal pro-B-type natriuretic peptide, troponin I, and C-reactive protein.RESULTS:The median cystatin C value was 0.83 mg/L. Increasing quartiles of cystatin C were strongly associated with poor outcome (6.9%, 7.1%, 9.5%, and 16.2%). The fully adjusted hazard ratios per SD of cystatin C in the NSTE-ACS and STE-ACS populations were 1.12 (95% CI 1.04-1.20) (n = 8053) and 1.06 (95% CI 0.97-1.17) (n = 5278), respectively. There was no significant relationship of cystatin C with type of ACS (STE or NSTE). c Statistics ranged from 0.6923 (cystatin C) to 0.6941 (CKD-EPI).CONCLUSIONS:Cystatin C concentration contributes independently in predicting the risk of cardiovascular death or myocardial infarction in NSTE-ACS, with no interaction by type of ACS. CKD-EPI exhibited the largest predictive value of all renal markers. Nevertheless, the additive predictive value of cystatin C or creatinine-based eGFR measures in the unselected ACS patient is small.

Skapa referenser, mejla, bekava och länka

Länka till träfflistan

Resultat 21-24 av 24

Avgränsa träffmängd

Typ av publikation: tidskriftsartikel (23); forskningsöversikt (1)

Typ av innehåll: refereegranskat (22); övrigt vetenskapligt/konstnärligt (2)

Författare/redaktör: Steg, Philippe Gabri ... (23); Wallentin, Lars (15); Husted, Steen (13); Storey, Robert F. (13); Harrington, Robert A (11); Becker, Richard C. (10); visa fler...; Cannon, Christopher ... (10); Huber, Kurt (8); James, Stefan K (7); Granger, Christopher ... (6); Held, Claes (6); Himmelmann, Anders (5); Katus, Hugo A (4); Wallentin, Lars, 194 ... (4); Lopes, Renato D. (4); Alexander, John H. (4); Thomas, Laine (4); Hanna, Michael (4); De Caterina, Raffael ... (4); McMurray, John J. V. (3); Wojdyla, Daniel M. (3); Hylek, Elaine M. (3); Alings, Marco (3); Emanuelsson, Håkan (3); Aylward, Philip (3); Keltai, Matyas (3); James, Stefan K., 19 ... (3); Valgimigli, Marco (3); Dallongeville, Jean (3); Banegas, José R (3); Atar, Dan (2); Collet, Jean-Philipp ... (2); Widimsky, Petr (2); Erol, Cetin (2); Perk, Joep (2); Harjola, Veli-Pekka (2); Al-Khatib, Sana M. (2); Vinereanu, Dragos (2); Commerford, Patrick (2); Ruzyllo, Witold (2); Cools, Frank (2); Lewis, Basil S. (2); Verheugt, Freek (2); Mahaffey, Kenneth W. (2); Morais, Joao (2); Lanas, Fernando (2); Ansell, Jack (2); Katus, Hugo (2); Bartunek, Jozef (2); Xavier, Denis (2); visa färre...

Lärosäte: Uppsala universitet (20); Linnéuniversitetet (3); Karolinska Institutet (2); Lunds universitet (1)

Språk: Engelska (24)

Forskningsämne (UKÄ/SCB): Medicin och hälsovetenskap (16)

År

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

Copyright © LIBRIS - Nationella bibliotekssystem
LIBRIS.kb.se

pil uppåt

Stäng

Kopiera och spara länken för att återkomma till aktuell vy